http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#Head http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://www.nanopub.org/nschema#hasAssertion http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://www.nanopub.org/nschema#hasProvenance http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#provenance http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://www.nanopub.org/nschema#hasPublicationInfo http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#pubinfo http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.nanopub.org/nschema#Nanopublication http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion http://purl.obolibrary.org/obo/MONDO_0002046 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Disease http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#object http://purl.obolibrary.org/obo/MONDO_0002046 http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate https://w3id.org/biolink/vocab/treats http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#subject https://go.drugbank.com/drugs/DB09072 http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association http://www.w3.org/1999/02/22-rdf-syntax-ns#type http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association http://www.w3.org/2000/01/rdf-schema#label nly a few medications are available for the treatment of alcohol use disorders (AUDs). Areas covered: This paper discusses approved AUD medications, including the opioid antagonists naltrexone and nalmefene (the latter is licensed for reduction of alcohol consumption only), the putative glutamate receptor antagonist acamprosate and the aldehyde dehydrogenase inhibitor disulfiram. It also covers off-label medications of interest, including topiramate, gabapentin, ondansetron, varenicline, baclofen, sodium oxybate and antidepressants. http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association https://w3id.org/biolink/vocab/association_type https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association https://w3id.org/biolink/vocab/provided_by https://w3id.org/um/NeuroDKG http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association https://w3id.org/biolink/vocab/publications https://pubmed.ncbi.nlm.nih.gov/28658981/ http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#association https://w3id.org/biolink/vocab/relation https://w3id.org/um/neurodkg/OffLabelIndication https://go.drugbank.com/drugs/DB09072 https://w3id.org/biolink/vocab/category https://w3id.org/biolink/vocab/Drug http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#provenance http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#assertion http://www.w3.org/ns/prov#wasAttributedTo https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#pubinfo http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig http://purl.org/nanopub/x/hasAlgorithm RSA http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig http://purl.org/nanopub/x/hasPublicKey MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCamPJb4SzqpLXn//XJ5dlVfzz6QI+RPmiJTLXF/by2JR7sHMKRsCQDFsYMlq8zGHghOIkjRP9dpLZUtZzUcHt3MXiFKEPo8eGzUe9p+JXKFC8xxkJr94z2vq6IdMf71Iu1GH8SeDAKt/DgYO4zNaw8VuXvxnZRewKZSA+u8zWPVwIDAQAB http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig http://purl.org/nanopub/x/hasSignature jeLBHsuUvsMdpK+yTeiGKnslFJ62Ok6aU3Avzs5TWiBSIJBTfQU3i36iUTypz+QhygVSY8gbi8jrFxhutgZ+1KE37rxxXx90C3Ki9covQ+CsI37DVncFf6YcjmWD52sYMSXjA8PLS50qYyoXVoYSwLoh09vMVyaywf+xa6pYF2g= http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I#sig http://purl.org/nanopub/x/hasSignatureTarget http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://purl.org/dc/terms/created 2021-08-25T19:58:40.391+02:00 http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://purl.org/dc/terms/creator https://orcid.org/0000-0002-7641-6446 http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I http://purl.org/nanopub/x/supersedes http://purl.org/np/RARopiC3OHJr16rOOFS8s8tm5HM1KFYYy8tJb7uqkdtYk http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate http://purl.org/np/RAjpBMlw3owYhJUBo3DtsuDlXsNAJ8cnGeWAutDVjuAuI http://purl.org/np/RAXQcejLx6RYB29gO_sTqk5PPrpPoUVqcaDm38QwJ0O7I https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate http://purl.org/np/RAZdZj78B6nKrP1Q00oFzsK07u7WdiY3sToz-H-H2nSgg